牛津大学的研究发现，Ozempic（索马鲁肽）可降低 48% 的痴呆风险，并减少认知能力下降和尼古丁的摄入。 Oxford University study finds Ozempic (semaglutide) may reduce dementia risk by 48% and lower cognitive decline and nicotine use.

牛津大学的一项研究表明，糖尿病治疗药物 Ozempic 可将患痴呆症的风险降低高达 48%。 A diabetes treatment drug, Ozempic, may reduce the risk of dementia by up to 48%, according to an Oxford University study. 这项研究发表在《柳叶刀》的电子临床医学杂志上，研究发现，Ozempic 或索马鲁肽不会增加任何神经或精神疾病的风险，服用 Ozempic 的患者的认知能力下降和尼古丁使用率较低。 The study, published in the Lancet's eClinicalMedicine journal, found that Ozempic, or semaglutide, was not associated with a higher risk of any neurological or psychiatric conditions, and patients taking Ozempic had lower rates of cognitive decline and nicotine use. 研究结果表明，使用司美鲁肽和类似药物治疗可能会降低痴呆症的风险，并有助于减少尼古丁成瘾。 The findings suggest that treatment with semaglutide and similar drugs may be associated with a lower risk of dementia and can help reduce nicotine addiction.